Teva Debuts US Rituximab At A 10% Discount

Truxima Biosimilar Rival To Rituxan Is Licensed From Celltrion

 
• By David Wallace
  
10_Per_Cent
Teva has launched the Truxima rituximab biosimilar at a 10% discount to Rituxan • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products